APA (7th ed.) Citation

Staso, R. D., Casadei, B., Locke, F. L., Jain, M., Voorhees, T. J., Kittai, A. S., . . . Argnani, L. Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Staso, Rossana Di, et al. Is CAR T a Drug or a Therapeutic Pathway? Intention to Treat Versus Per Protocol Analysis of Real World Studies of CAR-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma. Nature Publishing Group.

MLA (9th ed.) Citation

Staso, Rossana Di, et al. Is CAR T a Drug or a Therapeutic Pathway? Intention to Treat Versus Per Protocol Analysis of Real World Studies of CAR-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma. Nature Publishing Group.